Prognostic serum biomarkers for colorectal cancer – Review

Journal Title: Journal of Cancer Research & Therapy - Year 2018, Vol 6, Issue 1

Abstract

Background: Colorectal cancer (CRC) is one of the most common malignancies in developed countries. Research for diagnostic and prognostic biomarkers is increasing. There are more than 750,000 papers indexed in PubMed directly related to biomarkers. A lot of these papers claim to report clinically useful biomarkers. Unfortunately, very few serum biomarkers are in clinical use. Materials and methods: We performed a review for most of the published CRC serum biomarkers in the PubMed, Embase and Web of Science databases. Results: In total, 119 articles were obtained from the databases, of which 89 articles reporting on CRC serum prognostic markers were considered as relevant. In these studies, a total of 200 individual tumor markers were obtained. Conclusions: A general approach to understand how to predict clinical outcomes using risk, diagnostic, and prognostic biomarkers, is needed. In the future, serum biomarkers will drive advances in risk, diagnosis, and prognosis, they will be the targets of powerful molecular therapies, and they will individualize and optimize therapy.

Authors and Affiliations

Yovchev Y, Enchev E, Dimitrov E, Minkov G, Nikolov S

Keywords

Related Articles

Structural imaging of the pancreas in rat using micro-CT: application to a non-invasivelongitudinal evaluation of pancreatic ductal carcinoma monitoring

The aim of the study was to evaluate the feasibility of a longitudinal non-invasive monitoring of rat pancreatic ductal adenocarcinoma (PDAC) using microCTscans (μCT). The identification of the pancreatic gland on (μCT)...

Transcoelomic spread and ovarian seeding during ovulation: A possible pathogenesis of Krukenberg tumor

Krukenberg tumor is a metastatic ovarian tumor with its primary site being the gastrointestinal tract. The pathogenesis of Krukenberg tumor formation is still in its hypothetical stage though the current understanding su...

Economic evaluation of monoclonal antibody in the management of colorectal cancer

Objective: This study aims to determine the cost of colorectal cancer (CRC) management and compare the cost effectiveness of cetuximab and bevacizumab in the management of CRC. Method: This economic evaluation study from...

Characterizing tobacco use in an American cancer center’s catchment area can help direct future research priorities

Purpose: American cancer centers supported by the National Cancer Institute (NCI) must ensure that their research addresses the cancer relevant needs and risks of members of their catchment area. In 2016, the NCI support...

Current trends and controversies in the management of patients with splenic flexure tumours

Aim: There exists a variation in practice in the management of tumours around the splenic flexure. We aim to determine the current opinion regarding the management of these tumours. Methods: An anonymised 10-part online...

Download PDF file
  • EP ID EP523083
  • DOI 10.14312/2052-4994.2018-1
  • Views 49
  • Downloads 0

How To Cite

Yovchev Y, Enchev E, Dimitrov E, Minkov G, Nikolov S (2018). Prognostic serum biomarkers for colorectal cancer – Review. Journal of Cancer Research & Therapy, 6(1), 1-5. https://europub.co.uk/articles/-A-523083